NTES [NetEase,] 6-K: Form 6-K SIZE=”2″>TABLE OFNTENTS Page Page 3 Press

[Form 6-K SIZE="2">TABLE OFNTENTS Page Page 3 Press Release Regarding Earnings Results for the Fourth Quarter and Year Ended December 31, 2009,ted February 25, 2010 NETEASE.COM, Onward Choi Acting Chief Financial Officer Press Releasentact for Media and Investors: Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1)212-481-2050 LiJia SIZE="2">NetEase.com,]

By | 2016-02-03T22:35:04+00:00 February 25th, 2010|Categories: Chinese Stocks, NTES, Webplus ver|Tags: , , , , , |0 Comments

NTES [NetEase,] 6-K: (Original Filing)

[Form 6-K SIZE="2">TABLE OFNTENTS Page Page 3 Press Release Regarding Earnings Results for the Fourth Quarter and Year Ended December 31, 2009,ted February 25, 2010 NETEASE.COM, Onward Choi Acting Chief Financial Officer Press Releasentact for Media and Investors: Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1)212-481-2050 LiJia SIZE="2">NetEase.com,]

By | 2016-02-03T22:34:36+00:00 February 25th, 2010|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

NTES [NetEase,] 6-K: (Original Filing)

[Form 6-K SIZE="2">TABLE OFNTENTS Page Page 3 Press Release Regarding Earnings Results for the Fourth Quarter and Year Ended December 31, 2009,ted February 25, 2010 NETEASE.COM, Onward Choi Acting Chief Financial Officer Press Releasentact for Media and Investors: Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1)212-481-2050 LiJia SIZE="2">NetEase.com,]

By | 2016-02-03T14:37:43+00:00 February 25th, 2010|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

NTES [NetEase,] 6-K: Form 6-K SIZE=”2″>TABLE OFNTENTS Page Page 3 Press

[Form 6-K SIZE="2">TABLE OFNTENTS Page Page 3 Press Release Regarding Earnings Results for the Fourth Quarter and Year Ended December 31, 2009,ted February 25, 2010 NETEASE.COM, Onward Choi Acting Chief Financial Officer Press Releasentact for Media and Investors: Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1)212-481-2050 LiJia SIZE="2">NetEase.com,]

By | 2016-02-03T14:38:33+00:00 February 25th, 2010|Categories: Chinese Stocks, NTES, Webplus ver|Tags: , , , , , |0 Comments

NTES [NetEase,] 6-K: (Original Filing)

[Form 6-K SIZE="2">TABLE OFNTENTS Page Page 3 Press Release Regarding Earnings Results for the Fourth Quarter and Year Ended December 31, 2009,ted February 25, 2010 NETEASE.COM, Onward Choi Acting Chief Financial Officer Press Releasentact for Media and Investors: Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1)212-481-2050 LiJia SIZE="2">NetEase.com,]

By | 2016-02-03T08:44:12+00:00 February 25th, 2010|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

NTES [NetEase,] 6-K: Form 6-K SIZE=”2″>TABLE OFNTENTS Page Page 3 Press

[Form 6-K SIZE="2">TABLE OFNTENTS Page Page 3 Press Release Regarding Earnings Results for the Fourth Quarter and Year Ended December 31, 2009,ted February 25, 2010 NETEASE.COM, Onward Choi Acting Chief Financial Officer Press Releasentact for Media and Investors: Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1)212-481-2050 LiJia SIZE="2">NetEase.com,]

By | 2016-02-03T08:44:39+00:00 February 25th, 2010|Categories: Chinese Stocks, NTES, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Provides Preliminary 2009 Results: Revenue of $52 - $54 Million and Operating Income of $16 – $17 million excluding non-cash charges XIANYANG, China, February 25, 2010 (Xinhua-PRNewswire-FirstCall) Biostar expects to report gross margin for 2009 of approximately 71%, an increase of 1200 basis-points compared to 59% in 2008. Management anticipates unaudited operating income, excluding non-cash charges, of]

By | 2016-03-03T14:49:57+00:00 February 25th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Inc. Provides Preliminary 2009 Results: Revenue

[Biostar Pharmaceuticals, Inc. Provides Preliminary 2009 Results: Revenue of $52 - $54 Million and Operating Income of $16 – $17 million excluding non-cash charges XIANYANG, China, February 25, 2010 (Xinhua-PRNewswire-FirstCall) Biostar expects to report gross margin for 2009 of approximately 71%, an increase of 1200 basis-points compared to 59% in 2008. Management anticipates unaudited operating income, excluding non-cash charges, of]

By | 2016-03-03T14:50:50+00:00 February 25th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar